Aaron Lorenzo

Releasing a bit of good news, Chiron Corp. submitted a new drug application for Pulminiq inhalation solution for lung transplant patients. (BioWorld Today)

Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue

Oct. 15, 2004

By Aaron Lorenzo

Releasing a bit of good news, Chiron Corp. submitted a new drug application for Pulminiq inhalation solution for lung transplant patients. (BioWorld Today)

AtheroGenics Drops AGIX-4207 After Phase II Miss In Arthritis

Oct. 14, 2004

By Aaron Lorenzo

AtheroGenics Inc. is discontinuing the development of one of its investigational drugs following a Phase II failure. (BioWorld Today)

Aaron Lorenzo

ARTICLES

Vanda Raises $37M To Fund Clinical Product Development

Vanda Raises $37M To Fund Clinical Product Development

Phase III Ceplene Miss Fallout Continues; Maxim Cuts Staff

ViRexx Enters Agreement To Buy Familiar Firm: AltaRex

MacroGenics Raises $30M In Second-Round Financing

MacroGenics Raises $30M In Second-Round Financing

ViRexx Enters Agreement To Buy Familiar Firm: AltaRex

Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue

Chiron Files Pulminiq NDA As Feds Probe Flu Vaccine Miscue

AtheroGenics Drops AGIX-4207 After Phase II Miss In Arthritis

Today's news in brief

Today's news in brief

Cell/gene therapy sector now sustainable; China competition mounting

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

Neurotrimin unveiled as marker in intellectual disability